000 | 01127 a2200325 4500 | ||
---|---|---|---|
005 | 20250514235200.0 | ||
264 | 0 | _c20050901 | |
008 | 200509s 0 0 eng d | ||
022 | _a0009-9236 | ||
024 | 7 |
_a10.1016/j.clpt.2005.04.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aUyama, Yoshiaki | |
245 | 0 | 0 |
_aSuccessful bridging strategy based on ICH E5 guideline for drugs approved in Japan. _h[electronic resource] |
260 |
_bClinical pharmacology and therapeutics _cAug 2005 |
||
300 |
_a102-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aClinical Trials as Topic _xstandards |
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 | _aGuidelines as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInvestigational New Drug Application |
650 | 0 | 4 | _aJapan |
700 | 1 | _aShibata, Taro | |
700 | 1 | _aNagai, Naomi | |
700 | 1 | _aHanaoka, Hideki | |
700 | 1 | _aToyoshima, Satoshi | |
700 | 1 | _aMori, Kazuhiko | |
773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 78 _gno. 2 _gp. 102-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clpt.2005.04.001 _zAvailable from publisher's website |
999 |
_c15723317 _d15723317 |